Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: Involvement of c-Jun N- terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3395-3401

  Jun, Chang Duk ^a   Oh, Chun Do ^c   Kwak, Hyun Jeong ^a   Pae, Hyun Ock ^a   Yoo, Ji Chang ^a   Choi, Byung Min ^a   Chun, Jang Soo ^c   Park, Rae Kil ^a   Chung, Hun Taeg ^a,b  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; DNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROTEIN KINASE C; S NITROSOGLUTATHIONE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASE 3; CASPASES; CELL LINE; ENZYME ACTIVATION; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 0033559903     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002.
2. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1989. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem. Pharmacol. 38:1709.
3. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
4. Berdeaux, A. 1993. Nitric oxide: an ubiquitous messenger. Fundam. Clin. Pharmacol. 7:401.
5. Lowenstein, C. J., and S. H. Snyder, 1992. Nitric oxide, a novel biologic messenger. Cell 70:705.
6. Schmidt, H. H. H. W., S. M. Lohmann, and U. Walter. 1993. The nitric oxide and cGMP signal transduction system:regulation and mechanism of action. Biochem. Biophys. Acta 1178:153.
7. Corbett, J. A., J. R. Lancaster, Jr., M. A. Sweetland, and M. L. McDaniel, 1991. Interleukin-1β-induced formation of EPR-delectable iron-nitrosyl complexes in islets of Langerhans: role of nitric oxide in interleukin-1β-induced inhibition of insulin secretion. J. Biol. Chem. 266:21351.
8. McCartney-Francis, N., J. B. Allen, D. E. Mizel, J. E. Albina, Q.-W. Xie, C. F. Nathan, and S. M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749.
9. Weinberg, J. B., D. L. Granger, D. S. Pisetsky, M. F. Seldin, M. A. Misukonis, S. N. Mason, A. M. Pippen, P. Ruiz, E. R. Wood, and G. S. Gilkeson. 1994. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmume disease: increased nitric oxide production and nitric oxide synthase expression in MRL-1pr/1pr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J. Exp. Med. 179:651.
10. Brüne, B., and E. G. Lapetina. 1990. Properties of a novel nitric oxide-stimulated ADP-ribosyl transferase. Arch. Biochem. Biophys. 279:286.
11. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, Cebula T. A., W. H. Koch, A. W. Andrews, J. S. Allen, and L. K. Keefer. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254: 1001.
12. Stamler, J. S., D. J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox activated forms. Science 258:1898.
13. J. S. Stamler. 1994. Redox signalling: nitrosylation and related target interactions of nitric oxide. Cell 78:931.
14. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, T. Michel, D. J. Singel, and J. Loscalzo. 1992. S-nitrosylation of protein with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA 89:444
15. Nathan, C. F., and J. B. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
16. Karupiah, G., Q.-W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445.
17. Albina, J. E. S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080.
18. Cui, S., J. S. Reichner, R. B. Mateo, and J. E. Albina. 1994. Activated murine macrophages induced apoptosis in tumor cells through nitric oxide-dependent or-independent mechanisms. Cancer Res. 54:2462.
19. Messmer, U. K., E. G. Lapetina, and B. Brüne. 1995. Nitric oxide-induced apoptosis in RAW 264.7 macrophages in antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:757.
20. Arends, M. J., and A. H. Wyllie. 1991. Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32:221.
21. Ignarro, L. J. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535.
22. Mohr, S., J. S. Stamler, and B. Brüne. 1996. Posttranslational modification of glyceraldehyde-3-phosphale dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 271:4209.
23. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
24. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843.
25. Hunter, T. 1997. Oncoprotein networks. Cell 88:333.
26. Boulton, T. G., G. D. Yancopoulos, J. S. Gregory, C. Slaughter, C. Moomaw, J. Hsu, and M. H. Cobb. 1990. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64.
27. Zhou, G., Z. Q. Bao, and J. E. Dixon. 1995. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270:12665.
28. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinasse that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135.
29. Derijard, B., M. Hibi, I. H. Wu, T. Barret, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025.
30. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase sub-family of c-Jun kinases. Nature 369:156.
31. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmorality in mammalian cells. Science 265:808.
32. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanilo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock protein. Cell 78:1027.
33. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter. et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nuture 372:739.
34. Cano, E., and L. C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117.
35. Lander, H. M., A. T. Jacovina, R. J. Davis, and J. M. Tauras. 1996. Differential activation of mitogen-activated protein kinase by nitric oxide-related species J. Biol. Chem. 271:19705.
36. Park, D. S., L. Stefanis, C. Y. I. Yan, S. K. Farinelli, and L. A. Greene. 1996. Ordering the cell death pathway: differential effects of BCL2, an interleukin-1-converting enzyme family prolease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem. 271: 21898.
37. Messmer, U. K., and B. Brüne. 1997. Attenuation of p53 expression and Bax down-regulation during phorhol ester mediated inhibition of apoptosis. Br. J. Pharmacol. 121:625.
38. Goodnight, A., H. Mischack, W. Kolch, and J. F. Mushinski. 1995. Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH3T3 fibroblasts: isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes. J Biol. Chem. 270:9910.
39. Chun, J.-S., M.-J. Ha, and B. S. Jacobson. 1996. Differential translocation of protein kinase C-δ and -ε during HeLa cell adhesion to a gelatin substratum. J. Biol. Chem. 271:13008.
40. Mischack, H., J. Goodnight, W. Kolch, G. Martiny-Baron, C. Schaechtle, M. G. Kazanietz, P. M. Blumberg, J. H. Pierce, and J. F. Mushinski. 1993. Overexpression of protein kinase C-δ and -ε in NIH3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268:6090.
41. Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD-H) and the B cell antigen receptor. J. Immunol. 157:3181.
42. Wright, S. C., U. Schellenberger, H. Wang, D. H. Kinder, J. W. Talhouk, and J. W. Larrick. 1997. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J. Exp. Med. 106:1107.
43. Maciejewski, J. P., C. Selleri, T. Sato, H. J. Cho, H. J. Keefer, and C. F. Nathan. 1995. Nitric oxide supression of human hematopoiesis in vitro. contribution to inhibitory action of interferon-γ and tumor necrosis factor-α. J. Clin Invest. 96:1085.
44. Schwenger, P., P. Bellosta, I. Victor, C. Basilico, H. Y. Skolink, and J. Vilcek. 1997. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl. Acad. Sci. USA 94:2869.
45. Bitangcol, J. C., A. S. Chau, E. Stadnick, M. J. Lohka, B. Dicken, and E. K. Shibuya. 1998. Activation of the p42 mitogen-activated protein kinase pathway inhibit Cdc 2 activation and entry into M-phase in cycling Xenopus egg extracts. Mol. Biol. Cell. 9:451.
46. Jun, C. D., B. M. Choi, S. Y. Lee, S. S. Kang, H. M. Kim, and H. T. Chung. 1994. Nitric oxide inhibits the expression of protein kinase C δ gene in the murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 204:105.
47. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vailancourt, C. K. Ding, M. Gallant, Y. Gereau, P. R. Griftin, M. Lavelle, and Y. A. Lazebnik. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37.
48. Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T. T. Yamin, and D. W. Nicholson. 1996. CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271: 1841.
49. Jacobson, M. D., M. Weil, and M. C. Raff. 1996. Role of Ced-3/ICE-family protease in staurosporine-induced programmed cell death. J. Cell. Biol. 133:1041.
50. McConkey, D. J., P. Hartzell, M. Jonda, and S. Orrenius. 1989. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264:13399.
51. Haimovitz-Friedman, A., C. C. Kan, D. Ehleiter, R. S. Persaud, M. McLoughlin, Z. Fuks, and R. N. Kolesnik. 1994. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180:525.
52. Obeid, L. M., C. M. Linardie, L. A. Karolak, and Y. A. Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769.
53. Gubina, E., M. S. Rinaudo. Z. Szallasi, P. M. Blumberg, and R. A. Mufson. 1998. Overexpression of protein kinase C isotorm epsilon but not delta in human interleukin-3-dependent cells: supresses apoptosis and induced bcl-2 expression. Blood 91:823.
54. Murray, N. R., and A. P. Field. 1997. A typical protein kinase C t protects human leukemic cells against drug-induced apoplosis. J. Biol. Chem. 272:27521.
55. Jun, C. D., S. J. Park, B. M. Choi, H. J. Kwak, Y. C. Park, M. S. Kim, R. K. Park, and H. T. Chung. 1997. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells: association with enhanced fragmentation of mature genomic DNA. Cell. Immunol. 76:41.
56. Díaz-Guerra, M. J. M., O. G. Bodedón, M. Velasco, R. Whelan, P. J. Parker, and L. Boscá. 1996. Up-regulation of protein kinase C-ε promotes the expression of cytokine-inducihle nitric oxide synthase in RAW 264.7 cells. J. Biol. Chem. 271:32028.